|
|
|
03.04.26 - 15:24
|
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
VIGNEAU François
2.
Reason for the notification
a)
Position / status
Senior Vice President
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
529900JEHFM47DYY3S57
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (i...
|
|
|
03.04.26 - 12:00
|
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
ANNEXE B
Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF)
EUROFINS SCIENTIFIC SE – E1013
2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/A
3. Total number of shares composing the share capital of the notifying issuer 176,000,000
4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
365,011,719
5. Origin of the changeiii
Reduction in number of shares:
Cancellation of 6,163,000 shares
Reduction in numbers of voting rights:
Cancellation of some class A beneficiary units
P...
|
|
|
02.04.26 - 10:03
|
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Timothy Scott Oostdyck
2.
Reason for the notification
a)
Position / status
Member of Group Operating Council
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
529900JEHFM47DYY3S57
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transac...
|
|
|
01.04.26 - 07:21
|
Eurofins Announces the Cancellation of 6.163M Repurchased Shares (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company's share capital, that were repurchased as part of its share buyback programmes, which began in October 2022.
The cancellation of shares is in line with, among other objectives, the Company's intention to reduce the share capital as authorised by shareholders at the Annual General Meeting held on 24 April 2025.
Following this cancellation of repurchased shares, which is effective as of 31 March 2026, the total number of Eurofins shares outstanding is now 176,000,000.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanc...
|
|
|
31.03.26 - 15:36
|
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Val Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
52990...
|
|
|
30.03.26 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases from 23th March to 27th March 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
23/03/2026
FR0014000MR3
48 000
61.1218
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
23/03/2026
FR0014000MR3
12 000
61.2959
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
24/03/2026
FR0014000MR3
43 000
61.1757
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
24/03/2026
FR0014000MR3
7 000
61.2332
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
25/03/2026
FR0014000MR3
7 000
61.8379
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
25/03/2026
FR0014000MR3
43 000
61.7989
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
26/03/2026
FR0014000MR3
43 000
62.0870
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
26/03/2026
FR0014000MR3
7 000
62.1700
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
27/0...
|
|
|
|
|
26.03.26 - 14:12
|
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
VIGNEAU François
2.
Reason for the notification
a)
Position / status
Senior Vice President
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
529900JEHFM47DYY3S57
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type ...
|
|
|
23.03.26 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases From 16th March to 20th March 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the
Issuer
Identify code of the
Issuer
Transaction
day
Identify code of
the financial
instrument
Total daily
volume (in
number of
shares)
Daily
weighted
average
purchase
price of
the shares
Market
(MIC
Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
16/03/2026
FR0014000MR3
50 000
61.5297
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
17/03/2026
FR0014000MR3
50 000
61.8165
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
18/03/2026
FR0014000MR3
40 000
62.7347
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
18/03/2026
FR0014000MR3
10 000
62.7318
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
19/03/2026
FR0014000MR3
9 650
61.6796
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
19/03/2026
FR0014000MR3
40 350
61.6345
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
20/03/2026
FR0014000MR3
44 000
61.7853
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
20/03/2026
FR0014000MR3
6 000
61.7567
CEUX
TOTAL
250 000
61.9011
Transaction details...
|
|
|
23.03.26 - 17:12
|
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
...
|
|
|
23.03.26 - 07:18
|
Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Disclaimer: this document is a non-binding English translation of the convening notice of the shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting to be held on Thursday 23 April 2026 – the French version of the convening notice (“avis de convocation des actionnaires à l'assemblée générale ordinaire annuelle et une assemblée générale extraordinaire de la Société valant avis d'information des obligataires”) is the only official version. For the avoidance of doubt, in case of discrepancies between the French and the English version, the French version shall always prevail.
EUROFINS SCIENTIFIC SE
Société Européenne
Registered office: 23, Val Fleuri, L-1526 Luxembourg
Registre de Commerce et des Sociétés Luxembourg: B167775
(the “Company”)
The shareholders of the Company, and only with a consultative vote the holders of Deeply Subordinated Fixed to Floating Rate Bonds (ISIN: XS2579...
|
|
|
16.03.26 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases From 09th March to 13th March 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
09/03/2026
FR0014000MR3
10 000
63.1848
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
09/03/2026
FR0014000MR3
30 000
63.1292
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
10/03/2026
FR0014000MR3
30 000
64.2626
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
10/03/2026
FR0014000MR3
10 000
64.2183
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
11/03/2026
FR0014000MR3
10 000
63.2106
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
11/03/2026
FR0014000MR3
30 000
63.1997
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
12/03/2026
FR0014000MR3
40 000
62.4756
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
13/03/2026
FR0014000MR3
50 000
61.1391
XPAR
TOTAL
210 000
62.7612
Transaction details
In...
|
|
|
|
|
09.03.26 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
02/03/2026
FR0014000MR3
30 000
67.7739
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
02/03/2026
FR0014000MR3
10 000
67.7248
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
03/03/2026
FR0014000MR3
30 000
66.5836
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
03/03/2026
FR0014000MR3
10 000
66.5204
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
04/03/2026
FR0014000MR3
30 000
66.7649
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
04/03/2026
FR0014000MR3
10 000
66.7647
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
05/03/2026
FR0014000MR3
10 000
66.2541
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
05/03/2026
FR0014000MR3
30 000
66.3290
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
0...
|
|
|
02.03.26 - 17:48
|
Eurofins Scientific SE: Weekly Report on Share Repurchases from 23rd February to 27th February 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
23/02/2026
FR0014000MR3
30 000
66.9618
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
23/02/2026
FR0014000MR3
10 000
66.9085
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
24/02/2026
FR0014000MR3
10 000
66.9007
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
24/02/2026
FR0014000MR3
30 000
66.8455
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
25/02/2026
FR0014000MR3
10 000
67.3610
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
25/02/2026
FR0014000MR3
30 000
67.3045
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
26/02/2026
FR0014000MR3
10 000
67.2653
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
26/02/2026
FR0014000MR3
30 000
67.2336
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
2...
|
|
|
26.02.26 - 07:21
|
Eurofins announces the publication of its 2025 Annual Report and 2025 Environmental, Social and Governance Report (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF) has filed its 2025 Annual Report and its 2025 Environmental, Social and Governance Report for the year ended 31 December 2025 with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) on 26 February 2026. They are available on the Eurofins website, www.eurofins.com, under the heading Investors / Results and Presentations.
The Annual Report contains:
The Management Report
The Remuneration Report
The Corporate Governance Report
The Audited Annual Financial Statements
Notes to Editors:
For more information, please visit www.eurofins.com.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leade...
|
|
|
23.02.26 - 17:51
|
Eurofins Scientific SE: Weekly Report on Share Repurchases from 16th February to 20th February 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
16/02/2026
FR0014000MR3
30 000
64.6700
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
16/02/2026
FR0014000MR3
10 000
64.7116
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
17/02/2026
FR0014000MR3
40 000
65.8630
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
18/02/2026
FR0014000MR3
10 000
67.0861
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
18/02/2026
FR0014000MR3
30 000
66.9915
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
19/02/2026
FR0014000MR3
29 853
67.3868
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
19/02/2026
FR0014000MR3
147
68.2390
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
20/02/2026
FR0014000MR3
30 000
67.4653
XPAR
TOTAL
180 000
66.3779
Transact...
|
|
|
16.02.26 - 18:24
|
Eurofins Scientific : Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
529...
|
|
|
16.02.26 - 17:51
|
Eurofins: Weekly Report on Share Repurchases From 09th February to 13th February 2026 (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market (MIC Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
09/02/2026
FR0014000MR3
10 000
67.5833
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
10/02/2026
FR0014000MR3
15 000
67.4325
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
11/02/2026
FR0014000MR3
30 000
66.2403
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
11/02/2026
FR0014000MR3
10 000
66.0977
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
12/02/2026
FR0014000MR3
10 000
64.1236
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
12/02/2026
FR0014000MR3
30 000
64.1736
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
13/02/2026
FR0014000MR3
10 000
65.4891
CEUX
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
13/02/2026
FR0014000MR3
30 000
65.4570
XPAR
TOTAL
145 000
65.6590
Transaction details
In ac...
|
|
|
10.02.26 - 16:51
|
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
HILL Gavin
2.
Reason for the notification
a)
Position / status
Director
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
529900JEHFM47DYY3S57
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; an...
|
|